Cargando…

Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome

Alpha mannose-oligosaccharide (MOS) prebiotics are widely deployed in animal agriculture as immunomodulators as well as to enhance growth and gut health. Their mode of action is thought to be mediated through their impact on host microbial communities and their associated metabolism. Bio-Mos is a co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazlauskaite, Raminta, Cheaib, Bachar, Humble, Joseph, Heys, Chloe, Ijaz, Umer Zeeshan, Connelly, Stephanie, Sloan, William T., Russell, Julie, Martinez-Rubio, Laura, Sweetman, John, Kitts, Alex, McGinnity, Philip, Lyons, Philip, Llewellyn, Martin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241627/
https://www.ncbi.nlm.nih.gov/pubmed/35532227
http://dx.doi.org/10.1128/spectrum.01953-21
_version_ 1784737847876517888
author Kazlauskaite, Raminta
Cheaib, Bachar
Humble, Joseph
Heys, Chloe
Ijaz, Umer Zeeshan
Connelly, Stephanie
Sloan, William T.
Russell, Julie
Martinez-Rubio, Laura
Sweetman, John
Kitts, Alex
McGinnity, Philip
Lyons, Philip
Llewellyn, Martin S.
author_facet Kazlauskaite, Raminta
Cheaib, Bachar
Humble, Joseph
Heys, Chloe
Ijaz, Umer Zeeshan
Connelly, Stephanie
Sloan, William T.
Russell, Julie
Martinez-Rubio, Laura
Sweetman, John
Kitts, Alex
McGinnity, Philip
Lyons, Philip
Llewellyn, Martin S.
author_sort Kazlauskaite, Raminta
collection PubMed
description Alpha mannose-oligosaccharide (MOS) prebiotics are widely deployed in animal agriculture as immunomodulators as well as to enhance growth and gut health. Their mode of action is thought to be mediated through their impact on host microbial communities and their associated metabolism. Bio-Mos is a commercially available prebiotic currently used in the agri-feed industry, but studies show contrasting results of its effect on fish performance and feed efficiency. Thus, detailed studies are needed to investigate the effect of MOS supplements on the fish microbiome to enhance our understanding of the link between MOS and gut health. To assess Bio-Mos for potential use as a prebiotic growth promoter in salmonid aquaculture, we have modified an established Atlantic salmon in vitro gut model, SalmoSim, to evaluate its impact on the host microbial communities. The microbial communities obtained from ceca compartments from four adult farmed salmon were inoculated in biological triplicate reactors in SalmoSim. Prebiotic treatment was supplemented for 20 days, followed by a 6-day washout period. Inclusion of Bio-Mos in the media resulted in a significant increase in formate (P = 0.001), propionate (P = 0.037) and 3-methyl butanoic acid (P = 0.024) levels, correlated with increased abundances of several, principally, anaerobic microbial genera (Fusobacterium, Agarivorans, Pseudoalteromonas). DNA metabarcoding with the 16S rDNA marker confirmed a significant shift in microbial community composition in response to Bio-Mos supplementation with observed increase in lactic acid producing Carnobacterium. In conjunction with previous in vivo studies linking enhanced volatile fatty acid production alongside MOS supplementation to host growth and performance, our data suggest that Bio-Mos may be of value in salmonid production. Furthermore, our data highlights the potential role of in vitro gut models to complementin vivo trials of microbiome modulators. IMPORTANCE In this paper we report the results of the impact of a prebiotic (alpha-MOS supplementation) on microbial communities, using an in vitro simulator of the gut microbial environment of the Atlantic salmon. Our data suggest that Bio-Mos may be of value in salmonid production as it enhances volatile fatty acid production by the microbiota from salmon pyloric ceca and correlates with a significant shift in microbial community composition with observed increase in lactic acid producing Carnobacterium. In conjunction with previous in vivo studies linking enhanced volatile fatty acid production alongside MOS supplementation to host growth and performance, our data suggest that Bio-Mos may be of value in salmonid production. Furthermore, our data highlights the potential role of in vitro gut models to augment in vivo trials of microbiome modulators.
format Online
Article
Text
id pubmed-9241627
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-92416272022-06-30 Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome Kazlauskaite, Raminta Cheaib, Bachar Humble, Joseph Heys, Chloe Ijaz, Umer Zeeshan Connelly, Stephanie Sloan, William T. Russell, Julie Martinez-Rubio, Laura Sweetman, John Kitts, Alex McGinnity, Philip Lyons, Philip Llewellyn, Martin S. Microbiol Spectr Research Article Alpha mannose-oligosaccharide (MOS) prebiotics are widely deployed in animal agriculture as immunomodulators as well as to enhance growth and gut health. Their mode of action is thought to be mediated through their impact on host microbial communities and their associated metabolism. Bio-Mos is a commercially available prebiotic currently used in the agri-feed industry, but studies show contrasting results of its effect on fish performance and feed efficiency. Thus, detailed studies are needed to investigate the effect of MOS supplements on the fish microbiome to enhance our understanding of the link between MOS and gut health. To assess Bio-Mos for potential use as a prebiotic growth promoter in salmonid aquaculture, we have modified an established Atlantic salmon in vitro gut model, SalmoSim, to evaluate its impact on the host microbial communities. The microbial communities obtained from ceca compartments from four adult farmed salmon were inoculated in biological triplicate reactors in SalmoSim. Prebiotic treatment was supplemented for 20 days, followed by a 6-day washout period. Inclusion of Bio-Mos in the media resulted in a significant increase in formate (P = 0.001), propionate (P = 0.037) and 3-methyl butanoic acid (P = 0.024) levels, correlated with increased abundances of several, principally, anaerobic microbial genera (Fusobacterium, Agarivorans, Pseudoalteromonas). DNA metabarcoding with the 16S rDNA marker confirmed a significant shift in microbial community composition in response to Bio-Mos supplementation with observed increase in lactic acid producing Carnobacterium. In conjunction with previous in vivo studies linking enhanced volatile fatty acid production alongside MOS supplementation to host growth and performance, our data suggest that Bio-Mos may be of value in salmonid production. Furthermore, our data highlights the potential role of in vitro gut models to complementin vivo trials of microbiome modulators. IMPORTANCE In this paper we report the results of the impact of a prebiotic (alpha-MOS supplementation) on microbial communities, using an in vitro simulator of the gut microbial environment of the Atlantic salmon. Our data suggest that Bio-Mos may be of value in salmonid production as it enhances volatile fatty acid production by the microbiota from salmon pyloric ceca and correlates with a significant shift in microbial community composition with observed increase in lactic acid producing Carnobacterium. In conjunction with previous in vivo studies linking enhanced volatile fatty acid production alongside MOS supplementation to host growth and performance, our data suggest that Bio-Mos may be of value in salmonid production. Furthermore, our data highlights the potential role of in vitro gut models to augment in vivo trials of microbiome modulators. American Society for Microbiology 2022-05-09 /pmc/articles/PMC9241627/ /pubmed/35532227 http://dx.doi.org/10.1128/spectrum.01953-21 Text en Copyright © 2022 Kazlauskaite et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Kazlauskaite, Raminta
Cheaib, Bachar
Humble, Joseph
Heys, Chloe
Ijaz, Umer Zeeshan
Connelly, Stephanie
Sloan, William T.
Russell, Julie
Martinez-Rubio, Laura
Sweetman, John
Kitts, Alex
McGinnity, Philip
Lyons, Philip
Llewellyn, Martin S.
Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome
title Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome
title_full Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome
title_fullStr Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome
title_full_unstemmed Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome
title_short Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome
title_sort deploying an in vitro gut model to assay the impact of the mannan-oligosaccharide prebiotic bio-mos on the atlantic salmon (salmo salar) gut microbiome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241627/
https://www.ncbi.nlm.nih.gov/pubmed/35532227
http://dx.doi.org/10.1128/spectrum.01953-21
work_keys_str_mv AT kazlauskaiteraminta deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT cheaibbachar deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT humblejoseph deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT heyschloe deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT ijazumerzeeshan deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT connellystephanie deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT sloanwilliamt deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT russelljulie deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT martinezrubiolaura deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT sweetmanjohn deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT kittsalex deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT mcginnityphilip deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT lyonsphilip deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome
AT llewellynmartins deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome